الولايات المتحدة · منصات وبيانات · Morningstar

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026

نشره Morningstar · الولايات المتحدة منذ 16 س

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its…

اقرأ المقال كاملًا على Morningstar سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.morningstar.com)

يستحق القراءة أيضًا

The Motley Fool

Looking Beyond the S&P 500? These 2 International ETFs Offer Very Different Opportunities

MarketBeat

XY Planning Network Inc. Sells 5,331 Shares of NVIDIA Corporation $NVDA

MarketWatch

‘She’s living the dream’: My stepmother said I can buy my childhood home for $850,000. Is she taking advantage of me?

Investing.com

Story3 Capital Partners buys $2.25M in Rent the Runway shares

Seeking Alpha

Global X Equal Weight Can Insurance Idx ETF declares CAD 0.06 dividend

Yahoo Finance